Huidafwijkingen bij covid-19

Translated title of the contribution: Cutaneous lesions in COVID-19 patients

Z Çiftçi, J M K Clabbers, A F S Galimont-Collen, A Gostynski

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Aside from the typical respiratory symptoms resulting from an infection with SARS-CoV-2, there are reports of cutaneous lesions in patients diagnosed with a SARS-CoV-2 infection. There are reports of multiple groups of skin lesions presenting in different stages of this diagnosis. The most common reported groups are chilblains, vesicular eruptions, morbilliformexanthems, acute urticaria and livedo. It is unlikely that all these groups of skin lesions are distinctive of an infection with SARS-CoV-2. Chilblains of new onset, however, could possibly be a distinctive symptom of a mild/asymptomatic infection with SARS-CoV-2. It is recommended to consider an infection with SARS-CoV-2 in the differential diagnosis in patients presenting with these groups of skin lesions. Consider testing for SARS-CoV-2 and consult the dermatologist if needed, especially in case of chilblains, to ensure histopathological evaluation of the skin lesions to increase knowledge of the underlying pathophysiology.
Translated title of the contributionCutaneous lesions in COVID-19 patients
Original languageDutch
Article numberD5443
JournalNederlands Tijdschrift voor Geneeskunde
Volume164
Publication statusPublished - 3 Dec 2020

Keywords

  • Biopsy/methods
  • COVID-19/complications physiopathology virology
  • COVID-19 Testing
  • Chilblains/diagnosis
  • Diagnosis, Differential
  • Humans
  • SARS-CoV-2/isolation & purification
  • Skin Diseases/etiology pathology virology

Cite this